Navigation Links
Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
Date:4/28/2008

HAYWARD, Calif. and ST. LOUIS, April 28 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) and Mendel Biotechnology, Inc. today announced a collaborative agreement to enhance the development of Mendel's BioEnergy Seeds & Feedstocks business. Under the terms of the agreement, Mendel will benefit from Monsanto's industry-leading expertise in the testing, breeding, and development of crops.

Mendel and Monsanto have worked together on the development of biotechnology traits for more than a decade in many crops, including corn, soy, cotton and canola. In this new collaboration, the two companies will apply Monsanto's expertise in crop testing, breeding and seed production to perennial grass seed varieties Mendel is developing for use in biofuels and other commercial applications.

"Mendel sees a bright future for second generation biofuels. We recognize the need to continue growing our capabilities and expertise to enable us to best serve farmers and refiners with proprietary seed products," said Neal Gutterson, president and chief executive officer of Mendel. "Monsanto is the global leader in the development and commercialization of high-value, sustainable seed products. We are excited to work with Monsanto's outstanding technical team to enhance our ability to create high-performing dedicated energy crops."

"Monsanto has been committed to providing farmers with higher grain yields to help them meet demand for food, feed and fuel," said Steve Padgette, vice president of biotechnology at Monsanto. "This collaboration has the potential to advance discoveries in the next frontier: cellulosic biofuels. It also presents both companies with an opportunity to broaden our understanding of the strengths and potential applications of biomass grasses to biofuels production."

Cellulosic biofuels are made from leaves, stems, stalks or other typically non-edible parts of plants. Use of these renewable energy sources has the potential to greatly expand biofuel supply and also deliver environmental benefits such as reduced greenhouse gas emissions.

Mendel Biotechnology, Inc., has been a pioneer in the application of functional genomics to the study of plant genes. Mendel is also a pioneer for the production of dedicated energy crops critical for second generation biofuels. Mendel has identified and patented the use of genes that control many aspects of plant growth and development, and is using such inventions to develop or co-develop new plant varieties with improved productivity and quality. Mendel has relationships with leading agricultural, energy, forestry and horticulture companies for the commercialization of improved seed and plant products, and is developing new seed and feedstock products for the emerging bioenergy market. For more information, visit: http://www.mendelbio.com.

Monsanto Company is a leading provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see http://www.monsanto.com.


'/>"/>
SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Monsanto Executives to Address Investor Conferences in February
2. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
3. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
4. Monsanto and Devgen Describe New Approach to Insect-Protection
5. Monsanto Company Executives Adopt 10b5-1 Trading Plans
6. Science Magazine Recognizes Monsanto as Top Employer
7. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
8. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
9. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
10. Monsanto Company Signs Share Subscription Agreement With Devgen
11. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS ... the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, ... proud to add Target to its list of well-respected retailers. This list includes ...
Breaking Biology Technology:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
Breaking Biology News(10 mins):